March 9, 2022
Inside Precision Medicine featured recent University of Cincinnati research led by Dr. Trisha Wise-Draper showing adding immunotherapy to standard of care treatments for head and neck cancer increased survival rates for intermediate risk patients.
February 25, 2022
University of Cincinnati researchers led by Jiajie Diao and Yujie Sun have developed a new pH probe and imaging technique to provide researchers more information when studying diseases like cancer and Alzheimer's.
February 28, 2022
Researchers led by the University of Cincinnati's Dr. Trisha Wise-Draper led a clinical trial that showed immunotherapy drug pembrolizumab increased survival rates for head and neck cancer patients with intermediate risk.
March 15, 2022
55KRC featured University of Cincinnati researcher Jiajie Diao on the Simply Medicine program to discuss advances in a new probe and imaging technique to get a better view of human cells.
November 9, 2022
WCPO featured the University of Cincinnati's Rifat Wahab in an article about racial disparities in breast cancer diagnoses and work being done to address the issue.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.
June 28, 2022
MSN highlighted the University of Cincinnati's Jordan Kharofa and his recent research on how diet and the microbiome affect colorectal cancer risks in young populations.
June 6, 2022
The University of Cincinnati's Atsuo Sasaki and an international team of collaborators have been awarded a Human Frontier Science Program research grant to learn more about how cells migrate, with an ultimate goal of developing new treatments to prevent cancer growth and spread.
June 10, 2022
The University of Cincinnati's Pier Paolo Scaglioni, MD, has received a $1.5 million National Cancer Institute grant to continue research into the roles of the KRAS gene and lipids in lung cancer.